Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > NASH Protocol News Tomorrow?
View:
Post by SPCEO1 on May 19, 2021 11:50am

NASH Protocol News Tomorrow?

THTX will be having its fireside chat tomorrow with Canaccord at 2PM but I believe they also rescheduled an earlier call with NBF brokers until tomorrow at Noon. Could that rescheduling indicate we will get some news tomorrow? If so, I would guess it would be the finalized NASH phase III protocol since the meeting with the FDA about that likely took place some weeks ago and THTX was simply waiting for the official letter to arrive from the FDA before making any announcement. From what I recall, those letters typically are sent 30 days after the meeting and summarize the conclusion of the meeting. So, THTX already likely knows the outcome of the NASH protocol meeting with the FDA but has had to sit on it until the letter arrived - this is probably why Paul stated with great confidence that the NASH trial would get started in Q3.

That is my best guess. But it also may simply be informational meetings tommorrow with no news associated with it. We will know soon enough. I am hoping LSA will help them in leveraging such events with good news, however,
Comment by qwerty22 on May 19, 2021 12:15pm
Fingers-crossed. Definitely lots of colour and openness is needed to explain this program.  
Comment by palinc2000 on May 19, 2021 1:16pm
I dont think a low audience fire side chat would be a proper way to disseminate the news of the Final go ahead from FDA ,,,, I see another Investor Day with Grinspoon &al to explain in detail the Protocol and how it fits with known past results in trials and studies on Tesamorelin
Comment by SPCEO1 on May 19, 2021 1:57pm
That works for me!
Comment by scarlet1967 on May 19, 2021 4:40pm
It clearly states in the sec document that THTX will have to pay for IM. So even if company wanted to bypass that trial they would have needed Taimed's approval. I don't see why even go with IV push it might be faster but still an IV administration now IM is clearly much more convenient so it should be easier to start patient on it and better compliance. I just hope as you stated it will ...more  
Comment by scarlet1967 on May 19, 2021 4:42pm
That was related to the earlier post.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse